Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes

(2012) Cailin H. Sibley et al.   ARTHRITIS AND RHEUMATISM

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

(2012) Charles A. Dinarello et al.   NATURE REVIEWS DRUG DISCOVERY

Homeostatic Tissue Responses in Skin Biopsies from NOMID Patients with Constitutive Overproduction of IL-1β

(2012) Pamela Aubert et al.   PLoS One

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

(2011) Christina Kaiser et al.   RHEUMATOLOGY INTERNATIONAL

The emerging role of interleukin-1β in autoinflammatory diseases

(2010) Helen J. Lachmann et al.   ARTHRITIS AND RHEUMATISM

Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)

(2009) Hal M Hoffman   EXPERT OPINION ON BIOLOGICAL THERAPY

Anakinra for Rheumatoid Arthritis: A Systematic Review

(2009) M. MERTENS et al.   JOURNAL OF RHEUMATOLOGY